MagForce AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MGFRF research report →
Price Chart
About the company
MagForce AG focuses on innovative nanotechnology-driven cancer therapy, with operations spanning Germany and Poland. The company's key offerings include NanoTherm, a therapeutic solution for brain tumors; NanoPlan, specialized software designed to assist medical professionals in crafting optimal treatment strategies for NanoTherm; and the NanoActivator, a device engineered to generate magnetic fields. Established in 1997, MagForce AG maintains its primary office in Berlin, Germany.
- CEO
- Benjamin J. Lipps
- IPO
- 2018
- Employees
- 33
- HQ
- Berlin, DE
Get TickerSpark's AI analysis on MGFRF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $11.97K
- P/E
- -291.25
- PEG
- -2.91
- P/S
- 9.91
- P/B
- 129.91
- EV/EBITDA
- -5.15
- Div Yield
- 0.00%
- Gross Margin
- -89.95%
- Op Margin
- -1913.88%
- Net Margin
- -3004.20%
- ROE
- -33.92%
- ROIC
- -10.65%
Latest fiscal year · YoY change
- Revenue
- $351.98K-43.3%
- Gross Profit
- $-316,610-172.8%
- Op Income
- $-6,736,531.96
- Net Income
- $-10,574,258.13-171.7%
- EPS
- $-0.35-170.0%
- OCF Growth
- +27.2%
- FCF Growth
- +27.2%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 3.02
- RSI (14)
- 0
- Avg Volume
- 0
No earnings-call transcripts are available for MGFRF yet.
- Free Float
- 75.9%
- Shares Outstanding
- 29.93M
- Float Shares
- 22.71M
Our MGFRF coverage
Recent articles, reports, and earnings notes.
No research on MGFRF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MGFRF report →